This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Csir. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: The Innovative Contributions of Stephanie Fanucchi
Introduction
Stephanie Fanucchi is a prominent inventor based in Johannesburg, South Africa. She has made significant strides in the field of gene regulation through her innovative research and inventions. Her work focuses on understanding the complexities of gene expression and the mechanisms that govern it.
Latest Patents
Stephanie holds a patent for a groundbreaking invention titled "Site-specific nuclease single-cell assay targeting gene regulatory elements to silence gene expression." This invention relates to a single-cell assay designed to determine the effect of chromosomal contact on the transcriptional activity of genes of interest. It also includes methods for silencing gene expression by perturbing gene regulatory elements engaged in chromosomal contact. This patent showcases her expertise in molecular biology and genetic engineering.
Career Highlights
Stephanie is currently employed at the Council for Scientific and Industrial Research (CSIR), where she continues to push the boundaries of scientific research. Her career is marked by a commitment to advancing our understanding of gene regulation and its implications for various biological processes.
Collaborations
Throughout her career, Stephanie has collaborated with notable colleagues, including Youtaro Shibayama and Shaun Burd. These collaborations have enriched her research and contributed to the development of innovative solutions in the field of genetics.
Conclusion
Stephanie Fanucchi's contributions to the field of gene regulation through her patent and research at CSIR highlight her role as a leading inventor. Her work not only advances scientific knowledge but also has the potential to impact various applications in biotechnology and medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
